サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1578279

自己免疫疾患診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測

Global Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 231 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.38円
自己免疫疾患診断の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 231 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

自己免疫疾患診断市場の世界需要は、2023年の132億米ドルから2032年には193億5,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは4.34%です。

免疫システムは、多くの細菌、ウイルス感染、その他の疾患から身体を保護します。自己免疫疾患は、体内で起こる異常な免疫反応です。自己免疫疾患は、異物と戦う身体の能力を低下させ、その結果、自身の身体の組織を攻撃します。自己免疫疾患は男性よりも女性に多く見られます。クローン病、関節リウマチ、炎症性腸疾患、多発性硬化症、全身性エリテマトーデスなどは自己免疫疾患の一例です。いくつかのヘルスケアセンターでは、自己免疫疾患を診断するための多くの検査が市販されています。

市場力学

世界の自己免疫疾患診断市場は、政府資金の増加、診療所と診断センターの連携により成長が見込まれています。これに加えて、関節リウマチ、バセドウ病、橋本甲状腺疾患などの疾患の発生率の上昇が市場の成長を後押ししています。さらに、様々な自己免疫疾患に対する認識、医療分野の進歩、検査技術の向上なども需要を後押ししています。しかし、偽陽性の可能性が高く、診断検査結果が出るまでに時間がかかることが、市場成長の妨げになる可能性があります。さらに、発展、疾病予後のための新規バイオマーカーの進歩は、市場成長に新たな機会を提供する可能性が高いです。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、自己免疫疾患診断の世界市場における各セグメントを包括的に評価することもできます。自己免疫疾患診断業界の成長と動向は、この研究に全体的なアプローチを提供します。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 自己免疫疾患診断- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 自己免疫疾患診断の世界市場分析：検査タイプ別

  • 概要
  • 実績および予測データ分析
  • 抗核抗体検査
  • 自己抗体検査
  • 完全血球計算（CBC）
  • 総合代謝パネル
  • C反応性蛋白（CRP）検査
  • 赤血球沈降速度（ESR）
  • 尿検査
  • その他

第6章 自己免疫疾患診断の世界市場分析：疾患タイプ別

  • 概要
  • 実績および予測データ分析
  • バセドウ病
  • 橋本病
  • 多発性硬化症
  • 関節リウマチ
  • SLE（ループス）
  • 1型糖尿病
  • その他

第7章 自己免疫疾患診断の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第8章 自己免疫疾患診断企業の競合情勢

  • 自己免疫疾患診断市場競争
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott Laboratories Inc.
  • Beckman Coulter Inc.
  • BioMeRieux SA
  • Bio-Rad Laboratories
  • F. Hoffmann-La
  • Roche Ltd.
  • Inova Diagnostics Inc.
  • Quest Diagnostics
  • SQI Diagnostics Inc.
  • Siemens Healthcare
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Test Type (USD MN)
  • Antinuclear Antibody Test Market Sales By Geography (USD MN)
  • Autoantibody Test Market Sales By Geography (USD MN)
  • Complete Blood Count (CBC) Market Sales By Geography (USD MN)
  • Comprehensive Metabolic Panel Market Sales By Geography (USD MN)
  • C-reactive Protein (CRP) Test Market Sales By Geography (USD MN)
  • Erythrocyte Sedimentation Rate (ESR) Market Sales By Geography (USD MN)
  • Urinalysis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Disease Type (USD MN)
  • Graves' Disease Market Sales By Geography (USD MN)
  • Hashimoto's Thyroid its Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Rheumatoid Arthritis Market Sales By Geography (USD MN)
  • SLE (Lupus) Market Sales By Geography (USD MN)
  • Type 1 Diabetes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Autoimmune Disease Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Autoimmune Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Autoimmune Disease Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Disease Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Test Type (USD MN)
  • Antinuclear Antibody Test Market Sales By Geography (USD MN)
  • Autoantibody Test Market Sales By Geography (USD MN)
  • Complete Blood Count (CBC) Market Sales By Geography (USD MN)
  • Comprehensive Metabolic Panel Market Sales By Geography (USD MN)
  • C-reactive Protein (CRP) Test Market Sales By Geography (USD MN)
  • Erythrocyte Sedimentation Rate (ESR) Market Sales By Geography (USD MN)
  • Urinalysis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease Type (USD MN)
  • Graves' Disease Market Sales By Geography (USD MN)
  • Hashimoto's Thyroid its Market Sales By Geography (USD MN)
  • Multiple Sclerosis Market Sales By Geography (USD MN)
  • Rheumatoid Arthritis Market Sales By Geography (USD MN)
  • SLE (Lupus) Market Sales By Geography (USD MN)
  • Type 1 Diabetes Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11214429

The global demand for Autoimmune Disease Diagnostics Market is presumed to reach the market size of nearly USD 19.35 Billion by 2032 from USD 13.2 Billion in 2023 with a CAGR of 4.34% under the study period 2024-2032.

The immune system offers protection to the body from many bacterial, viral infections, and other diseases. The autoimmune disorder is an unusual immune response occurring in the body. Autoimmune diseases reduce the body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are many tests commercially available at several healthcare centers to diagnose autoimmune disorders.

MARKET DYNAMICS

The global autoimmune disease diagnostics market is expected to grow due to increased government funding, a collaboration of clinics and diagnostics centers. In addition to this, the rise in the incidence of diseases such as rheumatoid arthritis, Graves, and Hashimoto's thyroid disease drives the growth of the market. Further, awareness about the various autoimmune diseases, advancements in medical fields, improved laboratory techniques, and others are also propelling the demand. However, high chances of false-positive results and slow turnaround time for diagnostic test results may hamper the market growth. Moreover, the developments in an emerging market, advancement in novel biomarkers for the prognosis of diseases are likely to offer new opportunities in market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoimmune Disease Diagnostics. The growth and trends of Autoimmune Disease Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autoimmune Disease Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

  • Antinuclear Antibody Test
  • Autoantibody Test
  • Complete Blood Count (CBC)
  • Comprehensive Metabolic Panel
  • C-reactive Protein (CRP) Test
  • Erythrocyte Sedimentation Rate (ESR)
  • Urinalysis
  • Others

By Disease Type

  • Graves' Disease
  • Hashimoto's Thyroid its
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • SLE (Lupus)
  • Type 1 Diabetes
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autoimmune Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoimmune Disease Diagnostics market include Abbott Laboratories Inc., Beckman Coulter Inc., BioMeRieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics Inc., Quest Diagnostics, SQI Diagnostics Inc. Siemens Healthcare Among Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. AUTOIMMUNE DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By Disease Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

  • 5.1. Overview By Test Type
  • 5.2. Historical and Forecast Data Analysis By Test Type
  • 5.3. Antinuclear Antibody Test Historic and Forecast Sales By Regions
  • 5.4. Autoantibody Test Historic and Forecast Sales By Regions
  • 5.5. Complete Blood Count (CBC) Historic and Forecast Sales By Regions
  • 5.6. Comprehensive Metabolic Panel Historic and Forecast Sales By Regions
  • 5.7. C-reactive Protein (CRP) Test Historic and Forecast Sales By Regions
  • 5.8. Erythrocyte Sedimentation Rate (ESR) Historic and Forecast Sales By Regions
  • 5.9. Urinalysis Historic and Forecast Sales By Regions
  • 5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY DISEASE TYPE

  • 6.1. Overview By Disease Type
  • 6.2. Historical and Forecast Data Analysis By Disease Type
  • 6.3. Graves' Disease Historic and Forecast Sales By Regions
  • 6.4. Hashimoto's Thyroid its Historic and Forecast Sales By Regions
  • 6.5. Multiple Sclerosis Historic and Forecast Sales By Regions
  • 6.6. Rheumatoid Arthritis Historic and Forecast Sales By Regions
  • 6.7. SLE (Lupus) Historic and Forecast Sales By Regions
  • 6.8. Type 1 Diabetes Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE AUTOIMMUNE DISEASE DIAGNOSTICS COMPANIES

  • 8.1. Autoimmune Disease Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF AUTOIMMUNE DISEASE DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Beckman Coulter Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. BioMeRieux SA
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Bio-Rad Laboratories
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. F. Hoffmann-La
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Roche Ltd.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Inova Diagnostics Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Quest Diagnostics
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. SQI Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Siemens Healthcare
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies